IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cance... (

HOME >> MEDICINE >> TECHNOLOGY

IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients

Date:6/2/2008

- Data presented at 44th American Society of Clinical Oncology (ASCO) annual meeting further supports improvement in median survival vs. external

controls -

IRVINE, Calif., June 2 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (Nasdaq: IDMI) today announced follow-up results from the Phase 2 study of IDM-2101 showing that the product candidate was well tolerated, induced broadly specific cytotoxic T lymphocyte (CTL) responses, and showed a positive survival trend in HLA-A2 positive patients with non-small cell lung cancer (NSCLC) who were treated with IDM-2101, compared to a parallel external control group of HLA-A2 negative non-treated patients.

"We continue to be encouraged by the positive trend in overall survival we are seeing in patients treated with IDM-2101," said Minal Barve, M.D., practice director, Mary Crowley Cancer Research Center. "Based on the results to date, further clinical study is warranted to confirm the potential of IDM-2101 as a treatment option for patients with non-small cell lung cancer."

Trial Design and Results

The Phase 2 open label, non-randomized trial, was designed to assess one-year patient survival, overall survival and vaccine immunogenicity in HLA-A2 positive patients with stage IIIb, IV or recurrent NSCLC. Patients were required to have tumor volume less than 125 cm2 with no limits on prior chemotherapy. Sixty-eight patients were enrolled in the trial (sixty-three treated with one or more doses) with the last patient enrolled in March 2006. Patients are still being followed for long-term survival.

Results are as follows:

-- One-year survival IDM-2101 patients versus HLA-A2 negative patients

(n=72) but otherwise co
'/>"/>

SOURCE IDM Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India

Post Your Comments:

(Date:5/22/2013)... HARRISON, N.Y. , May 22, 2013 MGT ... the Company will present at the Second Annual Marcum ... New York City at the ... President and Chief Executive Officer, will update investors and ... The Company,s presentation is scheduled to begin ...

(Date:5/22/2013)... and TORONTO , May 22, 2013 ... today announced three presentations demonstrating the superiority of the ... subsidiary, Antigen Express, Inc. ( www.antigenexpress.com ). The presentations ... American Society of Clinical Oncology (ASCO) to be held ... through June 4, 2013. The presentation entitled ...

(Date:5/22/2013)... May 22, 2013 Grifols, a global healthcare company ... results from a study demonstrating that a higher dose ... increased levels of the alpha 1 protein in ... that are considered within the normal range for healthy ... which low levels of the alpha 1 proteinase ...

Breaking Medicine Technology:MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2 MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3 MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4 Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2 Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3 Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4 Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2 Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3 Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4

[0] MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference [0] Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine [0] Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency

... LOUIS, Oct. 14 Young Innovations, Inc. (Nasdaq: YDNT ) ... with a live and on-demand web cast conference call on Thursday, ... audio broadcast of the call will be available through InterCall at ... audio broadcast will also be available through the Company,s website, ...

... Oct. 14 In the United States, a woman is ... American Cancer Society. Except for skin cancers, breast cancer ... , To help fight this disease, eMed-ID, the ... for every pink Personal Health Records (PHR) wristband sold to ...

Cached Medicine Technology:Young Innovations, Inc. Provides Third Quarter Conference Call Details 2 Breast Cancer Survivors and Patients Encouraged to Have Medical History Readily Available 2 Breast Cancer Survivors and Patients Encouraged to Have Medical History Readily Available 3

Young Innovations, Inc. Provides Third Quarter Conference Call Details Breast Cancer Survivors and Patients Encouraged to Have Medical History Readily Available

(Date:5/22/2013)... Cedar Rapids, IA (PRWEB) May 22, 2013 ... inspirational theatre piece Handicap This! The performance promotes ... pursuing their dreams. The Handicap This! performance will be ... Linn Mar High School auditorium. Tickets for Handicap ... , Handicap This! helps audiences measure the level to ...

(Date:5/22/2013)... Twenty student-led startup companies at Arizona ... an intensive startup accelerator designed to help them execute ... create local jobs as part of ASU’s Edson ... initiative offers approximately 20 student teams up to $20,000 ... to launch their for-profit, more-than-profit or nonprofit ventures. The ...

(Date:5/22/2013)... ANN ARBORA University of Michigan study challenges previous ... League Baseball. , The study, a collaboration between ... and Florida, looks deeper into the controversial argument ... more strikes for pitchers of the same race. ... claim, said Jason Winfree, associate professor of sport ...

(Date:5/22/2013)... 22 (HealthDay News) -- Over the next two decades, ... is expected to more than double, topping more than ... The main factor driving the increase: an aging population. ... the American Stroke Association, was published May 22 in ... strain the health care system," Dr. Bruce Ovbiagele, chairman ...

(Date:5/22/2013)... researchers report that hospitals may be reaping enormous ... by preventable bloodstream infections contracted in their intensive ... reported online in the American Journal of ... ICU patient who develops an avoidable central line-associated ... to care for than a similar infection-free patient. ...

[0] Handicap This! Comes to Marion, Iowa [0] ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort [0] U-M study challenges notion that umpires call more strikes for pitchers of same race [0] Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report [0] Hospitals profit when patients develop bloodstream infections

... Fall, September 22, Focuses on Preventing Falls to ... issued,another call to action urging government, citizens and ... increasing number of falls,among people 65 years of ... Enzi (R-WY), as well as Representatives Frank Pallone ...

... Brookstone donates portion of sales of popular pink, ... Awareness Month, MIAMI BEACH, Fla., Sept. 22 ... have teamed up to provide,support for women diagnosed with ... of Breast Cancer Awareness Month., Through the ,Dash ...

... Partnership with AMICAS will enable practice,s strategic ... AMICAS, Inc. (Nasdaq: AMCS ),a leader ... management,solutions, today announced a new partnership with ... Medical Diagnostic Imaging Group (MDIG) of,Phoenix, AZ. ...

... Sept. 22 University of Pittsburgh scientists are uncovering more ... of Merkel cell carcinoma, an aggressive and deadly form of ... online edition of the Proceedings of the National Academy ... infects tumors that already have formed. If that were the ...

... SPECT Procedures ... ASNC Technology Standards, POWAY, Calif., Sept. 22 Digirad ... systems and,services to physicians, offices, hospitals and other medical services,providers, ... (FDA) 510(k) clearance for its new nSPEED(R) reconstruction,software -- for ...

... to Enhance Computer Security, ATLANTA, Sept. 22 ... providers, has published the locations,of the computers, from ... against its clients in 2008. The United States ... from computers within the,country and China ran second ...

Cached Medicine News:Health News:Home Safety Council(R) Applauds Creation of Falls Prevention Awareness Day 2 Health News:Nonprofit Charity for Women and Brookstone Dash to Fund Breast Cancer Support 2 Health News:Medical Diagnostic Imaging Group Chooses AMICAS 2 Health News:Medical Diagnostic Imaging Group Chooses AMICAS 3 Health News:Pitt research indicates new virus is culprit, not bystander, in deadly skin cancer 2 Health News:Digirad Corporation Receives FDA 510(k) Clearance for nSPEED(R) Reconstruction Software for Improved Image Quality in Less Time With Less Radiation 2 Health News:Digirad Corporation Receives FDA 510(k) Clearance for nSPEED(R) Reconstruction Software for Improved Image Quality in Less Time With Less Radiation 3 Health News:Compromised US and Chinese Computers Launch Greatest Number of Cyber Attacks, According to SecureWorks' Data 2 Health News:Compromised US and Chinese Computers Launch Greatest Number of Cyber Attacks, According to SecureWorks' Data 3

Home Safety Council(R) Applauds Creation of Falls Prevention Awareness Day Nonprofit Charity for Women and Brookstone Dash to Fund Breast Cancer Support Medical Diagnostic Imaging Group Chooses AMICAS Pitt research indicates new virus is culprit, not bystander, in deadly skin cancer Digirad Corporation Receives FDA 510(k) Clearance for nSPEED(R) Reconstruction Software for Improved Image Quality in Less Time With Less Radiation Compromised US and Chinese Computers Launch Greatest Number of Cyber Attacks, According to SecureWorks' Data

The ImagingPlanet 55 mm surgical microscope video adapter: superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Zeiss surgical ...

The ImagingPlanet 80 mm surgical microscope video adapter: superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Leica surgical...

The ImagingPlanet 80 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Zeiss surgical micro...

The ImagingPlanet 55 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Zeiss surgical micro...

Medicine Products:

Zeiss Z-55 Style Surgical Microscope Video Adapter from ImagingPlanet Leica L-80 Style Surgical Microscope Video Adapter from ImagingPlanet Zeiss® Z-80 Style Surgical Microscope Adapter from ImagingPlanet Zeiss® Z-55 Style Surgical Microscope Adapter from ImagingPlanet